Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2018 · 10-Q
Revenue$0.00$0.00— vs Q1 2017 Net Income-$3.85M-$3.85MN/M vs Q1 2017 EPS Diluted-$0.03-$0.03N/M vs Q1 2017 Operating Income-$1,683,227N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed Apr 23, 2018 · 23 d after period end